ATE197401T1 - Chinazolinon-arzneimittel sowie deren verwendung - Google Patents
Chinazolinon-arzneimittel sowie deren verwendungInfo
- Publication number
- ATE197401T1 ATE197401T1 AT95933731T AT95933731T ATE197401T1 AT E197401 T1 ATE197401 T1 AT E197401T1 AT 95933731 T AT95933731 T AT 95933731T AT 95933731 T AT95933731 T AT 95933731T AT E197401 T1 ATE197401 T1 AT E197401T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- hydrogen
- quinazolinone
- drugs
- lower alkoxy
- Prior art date
Links
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical compound C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000005605 benzo group Chemical group 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- -1 hydroxy, acetoxy Chemical group 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11083194A IL110831A (en) | 1994-08-31 | 1994-08-31 | Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis |
| PCT/US1995/011186 WO1996006616A1 (en) | 1994-08-31 | 1995-08-29 | Quinazolinone pharmaceuticals and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE197401T1 true ATE197401T1 (de) | 2000-11-11 |
Family
ID=11066514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95933731T ATE197401T1 (de) | 1994-08-31 | 1995-08-29 | Chinazolinon-arzneimittel sowie deren verwendung |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0787000B1 (de) |
| JP (1) | JPH10513149A (de) |
| CN (1) | CN1108797C (de) |
| AT (1) | ATE197401T1 (de) |
| AU (1) | AU692307B2 (de) |
| DE (1) | DE69519385T2 (de) |
| IL (1) | IL110831A (de) |
| WO (1) | WO1996006616A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL114951A (en) * | 1995-08-15 | 1999-08-17 | Hadasit Med Res Service | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization |
| JP2001500040A (ja) * | 1996-08-30 | 2001-01-09 | イスラエル国 | キナゾリノン誘導体を含有する冠状動脈内ステント |
| US6211188B1 (en) * | 1997-02-11 | 2001-04-03 | Hadasit Medical Research Services And Development Company Ltd | Treatment of skin disorders |
| US6028075A (en) | 1997-02-11 | 2000-02-22 | Pines; Mark | Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| US6562829B1 (en) | 1997-05-23 | 2003-05-13 | Hadasit Medical Research Services & Development Co., Ltd. | Treatment of hepatic cirrhosis |
| US6159488A (en) * | 1997-08-14 | 2000-12-12 | Agricultural Research Org. Ministry Of Agriculture (Gov.) | Intracoronary stents containing quinazolinone derivatives |
| ATE307586T1 (de) * | 1998-08-13 | 2005-11-15 | Hadasit Med Res Service | Hemmung von mit gewebetrauma verbundenen pathogenen prozessen |
| JP2002539262A (ja) * | 1999-03-19 | 2002-11-19 | パーカー ヒューズ インスティテュート | キナゾリン化合物製剤および治療におけるその使用 |
| US7064114B2 (en) | 1999-03-19 | 2006-06-20 | Parker Hughes Institute | Gel-microemulsion formulations |
| EP1210086B1 (de) * | 1999-09-09 | 2006-12-06 | Hadasit Medical Research Services & Development Co., Ltd. | Verwendung von halofuginone zur behandlung von urethralstriktur |
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| US6753428B2 (en) | 2001-11-20 | 2004-06-22 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
| WO2003070701A2 (en) | 2002-02-15 | 2003-08-28 | Cytokinetics, Inc. | Syntheses of quinazolinones |
| AU2003270015A1 (en) | 2002-05-09 | 2003-12-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| WO2003094839A2 (en) | 2002-05-09 | 2003-11-20 | Cytokinetics, Inc. | Pyrimidinone compounds, compositions and methods |
| JP2005536475A (ja) | 2002-05-23 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
| EP1556357A4 (de) | 2002-06-14 | 2006-09-13 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
| EP1537089A4 (de) | 2002-07-23 | 2008-04-16 | Cytokinetics Inc | Verbindungen, zusammenstellungen und verfahren |
| EP1558083A4 (de) | 2002-09-30 | 2008-04-16 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
| JP2007513154A (ja) | 2003-12-08 | 2007-05-24 | サイトキネティクス・インコーポレーテッド | 化合物、組成物及び方法 |
| KR20100024494A (ko) | 2007-06-22 | 2010-03-05 | 아르퀼 인코포레이티드 | 퀴나졸리논 화합물 및 이의 사용 방법 |
| CN114469956B (zh) * | 2022-01-29 | 2023-07-18 | 中国科学技术大学 | 常山酮在治疗和预防动脉粥样硬化性疾病的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US26833A (en) * | 1860-01-17 | Improvement in plows | ||
| US3320124A (en) * | 1964-07-20 | 1967-05-16 | American Cyanamid Co | Method for treating coccidiosis with quinazolinones |
| DE2934069A1 (de) * | 1979-08-23 | 1981-03-12 | Hoechst Ag, 6000 Frankfurt | Mittel gegen theileriosen und seine verwendung. |
| DE3703789A1 (de) * | 1987-02-07 | 1988-08-18 | Hoechst Ag | Coccidiozide mittel |
| CA2113229C (en) * | 1994-01-11 | 1999-04-20 | Mark Pines | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof |
-
1994
- 1994-08-31 IL IL11083194A patent/IL110831A/en not_active IP Right Cessation
-
1995
- 1995-08-29 AT AT95933731T patent/ATE197401T1/de not_active IP Right Cessation
- 1995-08-29 EP EP95933731A patent/EP0787000B1/de not_active Expired - Lifetime
- 1995-08-29 CN CN95195353A patent/CN1108797C/zh not_active Expired - Lifetime
- 1995-08-29 AU AU36268/95A patent/AU692307B2/en not_active Ceased
- 1995-08-29 JP JP8508990A patent/JPH10513149A/ja active Pending
- 1995-08-29 DE DE69519385T patent/DE69519385T2/de not_active Expired - Fee Related
- 1995-08-29 WO PCT/US1995/011186 patent/WO1996006616A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0787000A1 (de) | 1997-08-06 |
| JPH10513149A (ja) | 1998-12-15 |
| EP0787000B1 (de) | 2000-11-08 |
| AU3626895A (en) | 1996-03-22 |
| DE69519385D1 (de) | 2000-12-14 |
| WO1996006616A1 (en) | 1996-03-07 |
| CN1108797C (zh) | 2003-05-21 |
| IL110831A0 (en) | 1994-11-11 |
| CN1163566A (zh) | 1997-10-29 |
| AU692307B2 (en) | 1998-06-04 |
| IL110831A (en) | 1998-12-27 |
| DE69519385T2 (de) | 2001-03-15 |
| EP0787000A4 (de) | 1997-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE197401T1 (de) | Chinazolinon-arzneimittel sowie deren verwendung | |
| AU2003301020A1 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
| CA2280850A1 (en) | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies | |
| DK0749415T3 (da) | Benzamidanaloger, der er nyttige som PARP(ADP-ribosyltransferase, ADPRT) DNA-reparationsenzym-inhibitorer | |
| CO5031285A1 (es) | Triarilimidazoles | |
| TR199800697T2 (xx) | Farmas�tik olarak aktif kinazolin bile�imleri. | |
| EP0638567A4 (de) | Adenosin-aufnahme inhibitoren. | |
| UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
| UA35557C2 (uk) | Похідні 1,2,4-оксадіазолілфеноксіалкілізоксазолу, що мають противірусну активність та фармацевтична композиція на їх основі | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| SE9802208D0 (sv) | Novel compounds | |
| GEP20053626B (en) | Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof | |
| CA2360754A1 (en) | Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors | |
| ATE220908T1 (de) | Intracoronarer stent der quinazolinone derivate enthält | |
| RO117150B1 (ro) | Metodă pentru tratamentul afecţiunilor provocate de abuzul faţă de drog sau altă substanţă | |
| DE60013126D1 (de) | Ophthalmische histamin-enthaltende zusammensetzungen und deren verwendung | |
| PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
| SE9802209D0 (sv) | Novel compounds | |
| HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
| DK0850062T3 (da) | Anvendelse af halofuginon til fremstilling af et medikament til svækkelse af neovaskularisering og til behandling af maligne tumorer hos mennesker | |
| TR200001941T1 (tr) | TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri. | |
| ATE240329T1 (de) | Zytotoxische pyrido(2,3,4-kl)acridinderivate, ihre herstellung und therapeutische verwendung | |
| CA2198875A1 (en) | Quinazolinone pharmaceuticals and use thereof | |
| NZ309498A (en) | 2-substituted benzyl-benzimidazole derivatives as inhibitors of smooth muscle cell proliferation | |
| DK0777471T3 (da) | Inhibering af leukotrienbiosynese med urinstofderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |